Growth Metrics

Quest Diagnostics (DGX) Non-Current Debt: 2009-2025

Historic Non-Current Debt for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $5.2 billion.

  • Quest Diagnostics' Non-Current Debt fell 8.45% to $5.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year decrease of 8.45%. This contributed to the annual value of $5.6 billion for FY2024, which is 27.32% up from last year.
  • Latest data reveals that Quest Diagnostics reported Non-Current Debt of $5.2 billion as of Q3 2025, which was up 0.04% from $5.2 billion recorded in Q2 2025.
  • Quest Diagnostics' Non-Current Debt's 5-year high stood at $5.9 billion during Q1 2025, with a 5-year trough of $3.8 billion in Q2 2023.
  • Moreover, its 3-year median value for Non-Current Debt was $4.4 billion (2023), whereas its average is $4.7 billion.
  • Within the past 5 years, the most significant YoY rise in Quest Diagnostics' Non-Current Debt was 54.00% (2025), while the steepest drop was 8.45% (2025).
  • Quarterly analysis of 5 years shows Quest Diagnostics' Non-Current Debt stood at $4.0 billion in 2021, then decreased by 0.80% to $4.0 billion in 2022, then increased by 10.86% to $4.4 billion in 2023, then increased by 27.32% to $5.6 billion in 2024, then declined by 8.45% to $5.2 billion in 2025.
  • Its last three reported values are $5.2 billion in Q3 2025, $5.2 billion for Q2 2025, and $5.9 billion during Q1 2025.